Tim Inglis
Impact in
-
- Nosocomial Infections in ICU
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Burkholderia infections and melioidosis 4
- Sepsis Diagnosis and Treatment 2
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Paul R. Ingram (3 shared papers)David Speers (2 shared papers)Gerald B. Harnett (2 shared papers)Ronan J. Murray (2 shared papers)Gerard Ryan (1 shared paper)Emma Williamson (1 shared paper)Ian Arthur (1 shared paper)Jeffrey N Hanna (1 shared paper)
In The Last Decade
Tim Inglis
13 papers receiving 281 citations
Peers
Comparison fields: 5 of 55
- Critical Care and Intensive Care Medicine 53
- Molecular Medicine 48
- Endocrinology 33
- Applied Microbiology and Biotechnology 11
- Infectious Diseases 87
Countries citing papers authored by Tim Inglis
This map shows the geographic impact of Tim Inglis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Inglis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Inglis more than expected).
Fields of papers citing papers by Tim Inglis
This network shows the impact of papers produced by Tim Inglis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Inglis. The network helps show where Tim Inglis may publish in the future.
Co-authors
The 20 scholars most cited alongside Tim Inglis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 75 | |
| 2 | 2001 | 56 | |
| 3 | 1995 | 48 | |
| 4 | 2011 | 44 | |
| 5 | 2003 | 42 | |
| 6 | 2010 | 11 | |
| 7 | 2014 | 5 | |
| 8 | 2018 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2018 | 1 | |
| 12 | Melioidosis in man and other animals: epidemiology, ecology and pathogenesis | 2004 | 1 |
| 13 | 2011 | 1 | |
| 14 | 1996 | 0 |
About Tim Inglis
Tim Inglis is a scholar working on Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine, Family Practice and Public Health, Environmental and Occupational Health, having authored 14 papers that have together received 291 indexed citations. Recurring topics across this work include Burkholderia infections and melioidosis (4 papers), Clinical Reasoning and Diagnostic Skills (2 papers), Sepsis Diagnosis and Treatment (2 papers), Plant Disease Resistance and Genetics (1 paper), Infections and bacterial resistance (1 paper), Innovations in Medical Education (1 paper), Nosocomial Infections in ICU (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (53 citations), Molecular Medicine (48 citations), Endocrinology (33 citations), Applied Microbiology and Biotechnology (11 citations) and Infectious Diseases (87 citations). Tim Inglis has collaborated with scholars based in Australia, Singapore and Canada. Frequent co-authors include Paul R. Ingram, David Speers, Gerald B. Harnett, Ronan J. Murray, Gerard Ryan, Emma Williamson, Ian Arthur, Jeffrey N Hanna, Vicki Krause and Susan L. Hills. Their work appears in journals such as Journal of Medical Microbiology, Medical Teacher, Future Microbiology, Peritoneal Dialysis International and Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.